Clinicians and patients may consider this risk before initiating this GLP-1R agonist in those with a history of NAION, monocular patients and those with low vision at baseline, the researchers wrote in their abstract
It's extremely unlikely such symptoms are B6 related
The latter, while providing valuable real-world signals, are inherently susceptible to confounding by indication and selection bias, as patient characteristics and co-morbidities may differ significantly between treatment groups
Ambalaj her kullanmdan sonra skca kapatmak, ierideki rnlerin havayla temasn azaltarak etkinliini korur
Structural Basis for Homodimerization of the Src-Associated during Mitosis, 68-KDa Protein (Sam68) Qua1 Domain
Ho JY, Kraemer WJ, Volek JS, Fragala MS, Thomas GA, Dunn-Lewis C, Coday M, Hakkinen K, Maresh CM